Skip to main content
Clinical Trials/ITMCTR1900002299
ITMCTR1900002299
Not yet recruiting
Phase 1

Clinical study to evaluate the real curative effect of Chinese and western medicine in the treatment of precancerous gastric cancer by doctor-patient parallel medical record

Beijing Institute of Traditional Chinese Medicine Clinical Epidemiology and Evidence-Based Medicine Center0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Beijing Institute of Traditional Chinese Medicine Clinical Epidemiology and Evidence-Based Medicine Center
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Beijing Institute of Traditional Chinese Medicine Clinical Epidemiology and Evidence-Based Medicine Center

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients with precancerous lesions of the stomach that conform to the consensus opinion on chronic gastritis in China (2017, Shanghai) and the Kyoto global consensus opinion on helicobacter pylori gastritis; At the same time, the patient had the gastroscope and pathology of the first\-grade hospital within three months, and the pathological report was clearly one of atrophy, intestinal metaplasia and epithelial neoplasia (dysplasia);
  • (2\) aged between 30 and 70 years;
  • (3\) The patient or family member knows the content of the study and voluntarily signs the informed consent.

Exclusion Criteria

  • 1\. Pregnancy or pregnancy preparation;
  • 2\. With acute cerebral vascular disease;
  • 3\. Surgery, major posttraumatic;
  • 4\. Patients with known malignant tumors, severe chronic heart, liver, renal insufficiency, and immune deficiencyhigh grade epithelial neoplasia and more severe cases;
  • 5\. The patient has a major mental illness or has difficulty controlling his behavior;
  • 6\. The patient can not read, can not understand the informed consent or can not sign the informed consent by themselves.

Outcomes

Primary Outcomes

Not specified

Similar Trials